Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy

References

• Benson AB, D'Angelica MI, Abbott DE, et al. Nccn guidelines (r) insights hepatobiliary cancers, version 1.2017 featured updates to the nccn guidelines. J Natl Compr Canc Netw. 2017;15:563–573.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Kulik L, Heimbach JK, Zaiem F, et al. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta-analysis. Hepatology. 2018;67:381–400.
   PubMed Web of Science ®Google Scholar
• Xu XL, Liu XD, Liang M, et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology. 2018;287:461–472.
   PubMed Web of Science ®Google Scholar
• Ng KKC, Chok KSH, Chan ACY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma. Br J Surg. 2017;104:1775–1784.
   PubMed Web of Science ®Google Scholar
• Kim CG, Lee HW, Choi HJ, et al. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation. Cancer Med. 2019;8:5023–5032.
   PubMed Web of Science ®Google Scholar
• Allaire M, Rekik S, Layese R, et al. Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Dig Liver Dis. 2019;51:86–94.
   PubMedGoogle Scholar
• Cai XR, Chen ZH, Chen J, et al. Albumin-to-alkaline phosphatase ratio as an independent prognostic factor for overall survival of advanced hepatocellular carcinoma patients without receiving standard anti-cancer therapies. J Cancer. 2018;9:189–197.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Zhang XP, Cai XR, et al. The predictive value of albumin-to-alkaline phosphatase ratio for overall survival of hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy. J Cancer. 2018;9:3467–3478.
   PubMed Web of Science ®Google Scholar
• Chan AWH, Chan SL, Mo FKF, et al. Albumin-to-alkaline phosphatase ratio: A novel prognostic index for hepatocellular carcinoma. Dis Markers. 2015;2015:564057–564010.
   PubMed Web of Science ®Google Scholar
• Xiong JP, Long JY, Xu WY, et al. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery. WJGO. 2019;11:39–47.
   Web of Science ®Google Scholar
• Pu N, Gao SS, Xu YD, et al. Alkaline phosphatase-to-albumin ratio as a prognostic indicator in pancreatic ductal adenocarcinoma after curative resection. J Cancer. 2017;8:3362–3370.
   PubMed Web of Science ®Google Scholar
• Tan P, Xie N, Ai JZ, et al. The prognostic significance of albumin-to-alkaline phosphatase ratio in upper tract urothelial carcinoma. Sci Rep. 2018;8:12311.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Lin YX, Ye H, et al. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection. Int J Surg. 2016;36:143–151.
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang L, Wang YH, et al. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumour progression and prolongs overall survival in patients with intermediate (bclc b) hepatocellular carcinoma. Bmc Cancer. 2014;14:849.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al.; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update . Radiology. 2014;273:241–260.
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–7259.
   PubMed Web of Science ®Google Scholar
• Chun YS, Pawlik TM, Vauthey JN. 8th edition of the ajcc cancer staging manual: Pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25:845–847.
   PubMed Web of Science ®Google Scholar
• A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: The cancer of the liver italian program (clip) investigators. Hepatology (Baltimore, Md.). 1998;28:751–755.
   PubMed Web of Science ®Google Scholar
• Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918–928.
   PubMed Web of Science ®Google Scholar
• Kudo M, Chung HB, Osaki Y. Prognostic staging system for hepatocellular carcinoma (clip score): Its value and limitations, and a proposal for a new staging system, the japan integrated staging score (jis score). J Gastroenterol. 2003;38:207–215.
   PubMed Web of Science ®Google Scholar
• Farinati F, Vitale A, Spolverato G, et al.; ITA.LI.CA study group. Development and validation of a new prognostic system for patients with hepatocellular carcinoma. PLoS Med. 2016;13:e1002006.
   PubMed Web of Science ®Google Scholar
• Leung TWT, Tang AMY, Zee B, et al. Construction of the chinese university prognostic index for hepatocellular carcinoma and comparison with the tnm staging system, the okuda staging system, and the cancer of the liver italian program staging system - a study based on 926 patients. Cancer. 2002;94:1760–1769.
   PubMed Web of Science ®Google Scholar
• European Assoc Study L. Easl clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
   PubMed Web of Science ®Google Scholar
• D'Amico G, Morabito A, D'Amico M, et al. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis. Hepatol Inter. 2018;12:S34–S43.
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the albi grade. J Clin Oncol. 2015;33:550–545. U
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Awogi T, Okuyama K, et al. Nuclear localization of alkaline phosphatase in cultured human cancer cells. Med Electron Microsc. 2003;36:47–51.
   PubMedGoogle Scholar
• Iwadate Y, Matsutani T, Hirono S, et al. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma . J Neurooncol. 2016;129:101–107.
   PubMed Web of Science ®Google Scholar
• Yi JK, Mehrazarin S, Oh JE, et al. Osteo-/odontogenic differentiation of induced mesenchymal stem cells generated through epithelial-mesenchyme transition of cultured human keratinocytes. J Endod. 2014;40:1796–1801.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61:396–407.
   PubMed Web of Science ®Google Scholar
• Wang L, Li Q, Zhang J, et al. A novel prognostic scoring model based on albumin and γ-Glutamyltransferase for Hepatocellular Carcinoma Prognosis . Cancer Manag Res. 2019;11:10685–10694.
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Kaneko T, Saeed A, et al. Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: Adjunctive role of the albi grade. Cancers. 2020;12:1862.
   PubMed Web of Science ®Google Scholar
• Xiang X, You XM, Zhong JH, et al. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis b virus infection. J Hepatol. 2017;67:885–886.
   PubMed Web of Science ®Google Scholar
• Ince V, Akbulut S, Otan E, et al. Liver transplantation for hepatocellular carcinoma: Malatya experience and proposals for expanded criteria. J Gastrointest Cancer. 2020;51:998–1005.
   PubMed Web of Science ®Google Scholar